HCA Healthcare Inc. (HCA) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
HCA Healthcare Inc. (HCA) earns a Roarable Rating of B- (Buy) with 71/100 RQD Confidence. High-quality cash engine (41% profit margin, 19% return on capital) with steady institutional support. Even if the broader market gets choppy, the company’s underlying cash engine and big-money support put the odds in buyers’ favor.
How HCA Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $75.60B | 44% | 10.6% | $6.78B | $7.69B | 18.3% |
| FY 2024 | $70.60B | 44% | 9.6% | $5.76B | $5.64B | 15.8% |
| FY 2023 | $64.97B | 44% | 9.5% | $5.24B | $6.51B | 10.4% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring HCA)
- ✓Live walkthrough of HCA's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
HCA Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +7.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on HCA today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for HCA. Explore sector supply chains on /butterfly.
HCA Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is HCA Healthcare Inc. (HCA)?
In FY 2025 (10-K), HCA converted $75.6B of revenue into a 44% gross margin, 10.6% operating margin, and $7.7B in free cash flow (10.2% FCF margin).